KalVista Pharmaceuticals Inc (KALV)’s stock has witnessed a price declined of -7.20% from the previous close with its current price standing at $15.59. Its current price is -17.95% under its 52-week high of $19.00 and 113.56% more than its 52-week low of $7.30.
Additionally, it is important to take into account KALV stock ratios, including its price-to-sales ratio, which is 518.91 for the last tewlve months.KALV’s price to book ratio for the most recent quarter was 46.35, resulting in an 2.40 price to cash per share for the period.
How does KalVista Pharmaceuticals Inc (KALV) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
KalVista Pharmaceuticals Inc (KALV): Earnings History
If we examine KalVista Pharmaceuticals Inc’s recent earnings history, in the last quarter ended on 9/30/2025, it posted adjusted earnings per share of -$0.92, slashing the consensus of -$1.04. In other words, it beat the consensus by $0.12, resulting in a 11.54% surprise. In the 3 months period before the previous quarter which was closed on 9/30/2025, the stock recorded adjusted earnings per share of -$0.92 in contrast with the Outlook of -$1.04. That was a difference of $0.12 and a surprise of 11.54%.
KalVista Pharmaceuticals Inc (NASDAQ: KALV) Ownership Details
I will give a breakdown of the key shareholders in KalVista Pharmaceuticals Inc (KALV). Recent figures show that the company’s insiders hold 1.59% of shares. A total of 205 institutional investors hold shares in the company, making 124.17% of its stock and 126.18% of its float.
Sep 30, 2025, it was reported that the Company’s largest institutional holder is VR Adviser, LLC holding total of 6.73 shares that make 13.31% of the company’s total number of shares and are currently priced at 103.53 million.
The securities firm Tang Capital Management, LLC holds 5.04 shares of KALV, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 9.97%, and the holding percentage of shares is valued at 77.57 million.
